Atlas Trials

Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure:Phase I/II

Clinical trial NCT06195189 · RECRUITING

Trial details

NCT number
NCT06195189
Sponsor
Sichuan University
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2024-02-29
Primary completion
2027-12-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.